SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-463610
Filing Date
2012-11-09
Accepted
2012-11-09 17:04:28
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d398727d10q.htm 10-Q 511779
2 EX-31.1 d398727dex311.htm EX-31.1 6970
3 EX-31.2 d398727dex312.htm EX-31.2 7010
4 EX-32.1 d398727dex321.htm EX-32.1 3793
5 EX-32.2 d398727dex322.htm EX-32.2 3811
  Complete submission text file 0001193125-12-463610.txt   3030416

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT idra-20120930.xml EX-101.INS 341336
7 XBRL TAXONOMY EXTENSION SCHEMA idra-20120930.xsd EX-101.SCH 39404
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE idra-20120930_cal.xml EX-101.CAL 41179
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE idra-20120930_def.xml EX-101.DEF 70285
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE idra-20120930_lab.xml EX-101.LAB 246942
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idra-20120930_pre.xml EX-101.PRE 166963
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 121194486
SIC: 2836 Biological Products, (No Diagnostic Substances)